Research Topics
Genomes and GenesSpecies | A BersanoSummaryAffiliation: University of Milan Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Long term disability and social status change after Guillain-Barré syndromeA Bersano
Giorgio Spagnol Service of Clinical Neuroimmunology, Department of Neurological Sciences, Dino Ferrari Center, Milan University, IRCCS Ospedale Maggiore Policlinico, Italy
J Neurol 253:214-8. 2006..Treatment of GBS should not be only aimed at improving patients' disability but also at limiting the impact of the disease on their social life...
Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonismA Bersano
Department of Neurological Sciences Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, 7 IRCCS, Via F Sforza 35, Universita degli Studi di Milano, Milano, Italy
Eur J Intern Med 19:370-1. 2008..IFN-based therapy has been associated with high rates (20%) of central nervous system side effects, but only a few case reports exist on extrapyramidal side effects...- Aphasia burden to hospitalised acute stroke patients: need for an early rehabilitation programmeA Bersano
Department of Neurological Sciences, Neurology Unit, Milan University, Milan, Italy
Int J Stroke 4:443-7. 2009..The aim of our study is to evaluate the frequency of aphasia and to describe the characteristics of aphasics among a large sample of acute stroke patients in Italy... - Transthyretin Asn90 variant: amyloidogenic or non-amyloidogenic roleA Bersano
Department of Neurological Sciences, Dino Ferrari Centre, University of Milan, Milan, Italy
J Neurol Sci 284:113-5. 2009..It has still to be established whether other gene variants in our patient could act synergistically with His90Asn TTR mutation in increasing the risk of CNS haemorrhages... - Statins and strokeA Bersano
IRCCS Foundation Ospedale Maggiore Policlinico Mangiagalli and Regina Elena, Via F Sforza 35, 20122 Milan, Italy
Curr Med Chem 15:2380-92. 2008..Moreover, the low incidence and reversibility of adverse effects, and the unclear association with hemorrhagic events, support the safe use of these drugs... - Stenting for the treatment of high-grade intracranial stenosesS Lanfranconi
Centro Dino Ferrari, Universita degli Studi di Milano, Milan, Italy
J Neurol 257:1899-908. 2010..Our study confirms that endovascular treatment can be performed with a high technical success rate, even though the safety of these devices has still to be demonstrated... - Growth factors in ischemic strokeS Lanfranconi
Dipartimento di Scienze Neurologiche, Dino Ferrari Centre, IRCCS Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Universita degli Studi di Milano, Milan, Italy
J Cell Mol Med 15:1645-87. 2011..We provide a comprehensive and critical view of the present knowledge about GFs and stroke, and an overview of ongoing and future prospects... - Safety of carotid stenting for stroke prevention: need of an independent outcome assessorS Lanfranconi
Department of Neurological Sciences Neurology Unit, Foundation Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milan University, Via Francesco Sforza, 35, 20122, Milan, Italy
Neurol Sci 30:93-7. 2009..These findings could be partly explained by the unemployment of distal protection devices, but also by the presence of an independent observer that might have increased the accuracy of neurological evaluation... 
Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive ImpairmentS Lanfranconi
Department of Neurological Sciences, Dino Ferrari Centre, University of Milan, 20122 Milan, Italy
Neurol Res Int 2011:859802. 2011..The pattern of involvement of both peripheral and central nervous system dysfunction might suggest a common pathogenic mechanism, involving impaired cholinergic transmission...- Genetic polymorphisms for the study of multifactorial strokeA Bersano
Dipartimento di Scienze Neurologiche, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Istituto di Ricerca e Cura a Carattere Scientifico IRCCS, Universita degli Studi di Milano, Milano, Italy
Hum Mutat 29:776-95. 2008..Our findings could represent a useful tool to address further molecular investigations and to realize more detailed meta-analyses... - Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction blockE Nobile-Orazio
Giorgio Spagnol Service of Clinical Neuroimmunology, Department of Neurological Sciences, Dino Ferrari Centre, Milan University, IRCCS Ospedale Maggiore Policlinico, Milan, Italy
J Neurol Neurosurg Psychiatry 72:761-6. 2002.... - Stroke units in ItalyL Candelise
Dipartimento di Scienze Neurologiche, Milan, Italy
Neurol Sci 27:S223-4. 2006..Notwithstanding we found an increase of 30% in the number of SUs, at least in the regions previously evaluated, there is still a shortage of SU beds and high regional heterogeneity... - Genetics of cerebral hemorrhage and microbleedsS Lanfranconi
Department of Neurological Sciences, IRCCS Foundation Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, IRCCS, Milan University, Milan, Italy
Panminerva Med 55:11-28. 2013.... - Monogenic vessel diseases related to ischemic stroke: a clinical approachE Ballabio
Dipartimento di Scienze Neurologiche, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, IRCCS, Via F Sforza 35 Università degli Studi di Milano, Milano, Italy
J Cereb Blood Flow Metab 27:1649-62. 2007..This review could be useful to identify specific diagnostic pathways for patients with a suspicion of monogenic disease... - Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhageE R Zanier
Neurosurgical Intensive Care Unit, Department of Anesthesia and Critical Care Medicine, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, University of Milano, Milano, Italy
Acta Neurochir Suppl 102:339-43. 2008..The goal of this study was to measure H-FABP and tau in cerebrospinal fluid (CSF) following SAH to test the hypothesis that a relationship exists between SAH severity and H-FABP/tau values... - How long is IVIg effective in multifocal motor neuropathy?F Terenghi
Giorgio Spagnol Service of Clinical Neuroimmunology, Dino Ferrari Centre, Department of Neurological Sciences, Milan University, IRCCS Ospedale Maggiore Policlinico, Milan, Italy
Neurology 62:666-8. 2004..019). The effectiveness of IVIg in MMN often declines after several years possibly associated with the development of axonal degeneration... - Treatment of multifocal motor neuropathyE Nobile-Orazio
Giorgio Spagnol Service of Clinical Neuroimmunology, Department of Neurological Sciences, University of Milan IRCCS Ospedale Maggiore Policlinico, Via F. Sforza 35, 20122, Milan, Italy
Neurol Sci 24:S251-5. 2003..In most patients, however, the effects of this therapy only last a few weeks and improvement has to be maintained with periodic infusions for long periods of time, if not indefinitely... - High-dose intravenous immunoglobulin therapy in dysimmune neuropathiesE Nobile-Orazio
Giorgio Spagnol Neuroimmunology Service, Dino Ferrari Centre, Department of Neurological Sciences, Milan University, IRCCS Ospedale Maggiore Policlinico, Via Francesco Sforza 35, I-20122 Milan, Italy
Neurol Sci 23:S25-32. 2002 - Stroke Unit care in Italy. Results from PROSIT (Project on Stroke Services in Italy). A nationwide studyA Bersano
Dipartimento di Scienze Neurologiche, Ospedale Maggiore Policlinico, , Via F. Sforza 35, I-20122 Milan, Italy
Neurol Sci 27:332-9. 2006..The utility of these structural and performance characteristics needs validation from outcome studies...